A pan-cancer analysis of the prognostic implication and oncogenic role of tubulin epsilon and delta complex 2 (TEDC2) in human tumors
IntroductionTubulin epsilon and delta complex 2 (TEDC2) is widely expressed in various human tissues and primarily governs centriole stability. However, the biological significance of TEDC2 in pan-cancer is unclear.MethodsIn this study, we employed R software and various online bioinformatics analys...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-01-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1272108/full |
| _version_ | 1797366745492619264 |
|---|---|
| author | Yang Liu Jie Zhu Jing Shen Yuting Lu Ke Pan Chuan Tong Yao Wang |
| author_facet | Yang Liu Jie Zhu Jing Shen Yuting Lu Ke Pan Chuan Tong Yao Wang |
| author_sort | Yang Liu |
| collection | DOAJ |
| description | IntroductionTubulin epsilon and delta complex 2 (TEDC2) is widely expressed in various human tissues and primarily governs centriole stability. However, the biological significance of TEDC2 in pan-cancer is unclear.MethodsIn this study, we employed R software and various online bioinformatics analysis tools to investigate the functional attributes of TEDC2 in human tumours and its potential involvement in immune response. The status of TEDC2 expression was evaluated in samples from the TCGA and GEO datasets, as well as in tumour and corresponding normal samples from the TCGA database. Subsequently, Kaplan-Meier estimates, clinical correlations, and univariate Cox regressions were used to analyze the 33 types of tumors from TCGA and determine the prognostic significance of TEDC2. Moreover, nomogram models were formulated using three distinct tumours, namely kidney renal clear cell carcinoma (KIRC), lung adenocarcinoma (LUAD), and liver hepatocellular carcinoma (LIHC), to evaluate the prognostic significance of TEDC2 in tumours. Furthermore, TEDC2 was investigated for its correlation with the levels of immune cell infiltration, and a functional enrichment analysis was conducted to identify potential signalling pathways involving TEDC2. ResultsDifferential analysis revealed that 16 tumour types expressed TEDC2 to a greater extent than normal tissues. The abnormal expression of TEDC2 can predict survival outcomes in patients with adrenocortical carcinoma (ACC), KIRC, kidney renal papillary cell carcinoma (KIRP), LUAD, LIHC, lower grade glioma (LGG), and thymoma (THYM). Subsequent results indicated that TEDC2 has the ability to influence ECM regulators, cell cycle, and Immune checkpoint-associated signalling pathways, which could potentially lead to a poor prognosis and tumour progression.DiscussionTEDC2 has been identified as a potential therapeutic target that could predict the prognosis of multiple tumour types, making it a promising target for reversing tumour development. |
| first_indexed | 2024-03-08T17:08:21Z |
| format | Article |
| id | doaj.art-a9b78221dfcf422d81f3afa88a41c670 |
| institution | Directory Open Access Journal |
| issn | 1664-3224 |
| language | English |
| last_indexed | 2024-03-08T17:08:21Z |
| publishDate | 2024-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj.art-a9b78221dfcf422d81f3afa88a41c6702024-01-04T04:19:36ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-01-011410.3389/fimmu.2023.12721081272108A pan-cancer analysis of the prognostic implication and oncogenic role of tubulin epsilon and delta complex 2 (TEDC2) in human tumorsYang Liu0Jie Zhu1Jing Shen2Yuting Lu3Ke Pan4Chuan Tong5Yao Wang6Faculty of Hepato-Pancreato-Biliary Surgery, the First Medical Centre, Chinese PLA General Hospital, Beijing, ChinaSenior Departments of Urology, the Third Medical Centre, Chinese PLA General Hospital, Beijing, ChinaDepartment of Endocrinology, the Eighth Medical Center of PLA General Hospital, Beijing, ChinaDepartment of Bio-therapeutic, the First Medical Center, Chinese PLA General Hospital, Beijing, ChinaFaculty of Hepato-Pancreato-Biliary Surgery, the First Medical Centre, Chinese PLA General Hospital, Beijing, ChinaDepartment of Bio-therapeutic, the First Medical Center, Chinese PLA General Hospital, Beijing, ChinaDepartment of Bio-therapeutic, the First Medical Center, Chinese PLA General Hospital, Beijing, ChinaIntroductionTubulin epsilon and delta complex 2 (TEDC2) is widely expressed in various human tissues and primarily governs centriole stability. However, the biological significance of TEDC2 in pan-cancer is unclear.MethodsIn this study, we employed R software and various online bioinformatics analysis tools to investigate the functional attributes of TEDC2 in human tumours and its potential involvement in immune response. The status of TEDC2 expression was evaluated in samples from the TCGA and GEO datasets, as well as in tumour and corresponding normal samples from the TCGA database. Subsequently, Kaplan-Meier estimates, clinical correlations, and univariate Cox regressions were used to analyze the 33 types of tumors from TCGA and determine the prognostic significance of TEDC2. Moreover, nomogram models were formulated using three distinct tumours, namely kidney renal clear cell carcinoma (KIRC), lung adenocarcinoma (LUAD), and liver hepatocellular carcinoma (LIHC), to evaluate the prognostic significance of TEDC2 in tumours. Furthermore, TEDC2 was investigated for its correlation with the levels of immune cell infiltration, and a functional enrichment analysis was conducted to identify potential signalling pathways involving TEDC2. ResultsDifferential analysis revealed that 16 tumour types expressed TEDC2 to a greater extent than normal tissues. The abnormal expression of TEDC2 can predict survival outcomes in patients with adrenocortical carcinoma (ACC), KIRC, kidney renal papillary cell carcinoma (KIRP), LUAD, LIHC, lower grade glioma (LGG), and thymoma (THYM). Subsequent results indicated that TEDC2 has the ability to influence ECM regulators, cell cycle, and Immune checkpoint-associated signalling pathways, which could potentially lead to a poor prognosis and tumour progression.DiscussionTEDC2 has been identified as a potential therapeutic target that could predict the prognosis of multiple tumour types, making it a promising target for reversing tumour development.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1272108/fullimmune infiltrationtumor microenvironmentpan-cancerprognosisTEDC2 |
| spellingShingle | Yang Liu Jie Zhu Jing Shen Yuting Lu Ke Pan Chuan Tong Yao Wang A pan-cancer analysis of the prognostic implication and oncogenic role of tubulin epsilon and delta complex 2 (TEDC2) in human tumors Frontiers in Immunology immune infiltration tumor microenvironment pan-cancer prognosis TEDC2 |
| title | A pan-cancer analysis of the prognostic implication and oncogenic role of tubulin epsilon and delta complex 2 (TEDC2) in human tumors |
| title_full | A pan-cancer analysis of the prognostic implication and oncogenic role of tubulin epsilon and delta complex 2 (TEDC2) in human tumors |
| title_fullStr | A pan-cancer analysis of the prognostic implication and oncogenic role of tubulin epsilon and delta complex 2 (TEDC2) in human tumors |
| title_full_unstemmed | A pan-cancer analysis of the prognostic implication and oncogenic role of tubulin epsilon and delta complex 2 (TEDC2) in human tumors |
| title_short | A pan-cancer analysis of the prognostic implication and oncogenic role of tubulin epsilon and delta complex 2 (TEDC2) in human tumors |
| title_sort | pan cancer analysis of the prognostic implication and oncogenic role of tubulin epsilon and delta complex 2 tedc2 in human tumors |
| topic | immune infiltration tumor microenvironment pan-cancer prognosis TEDC2 |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1272108/full |
| work_keys_str_mv | AT yangliu apancanceranalysisoftheprognosticimplicationandoncogenicroleoftubulinepsilonanddeltacomplex2tedc2inhumantumors AT jiezhu apancanceranalysisoftheprognosticimplicationandoncogenicroleoftubulinepsilonanddeltacomplex2tedc2inhumantumors AT jingshen apancanceranalysisoftheprognosticimplicationandoncogenicroleoftubulinepsilonanddeltacomplex2tedc2inhumantumors AT yutinglu apancanceranalysisoftheprognosticimplicationandoncogenicroleoftubulinepsilonanddeltacomplex2tedc2inhumantumors AT kepan apancanceranalysisoftheprognosticimplicationandoncogenicroleoftubulinepsilonanddeltacomplex2tedc2inhumantumors AT chuantong apancanceranalysisoftheprognosticimplicationandoncogenicroleoftubulinepsilonanddeltacomplex2tedc2inhumantumors AT yaowang apancanceranalysisoftheprognosticimplicationandoncogenicroleoftubulinepsilonanddeltacomplex2tedc2inhumantumors AT yangliu pancanceranalysisoftheprognosticimplicationandoncogenicroleoftubulinepsilonanddeltacomplex2tedc2inhumantumors AT jiezhu pancanceranalysisoftheprognosticimplicationandoncogenicroleoftubulinepsilonanddeltacomplex2tedc2inhumantumors AT jingshen pancanceranalysisoftheprognosticimplicationandoncogenicroleoftubulinepsilonanddeltacomplex2tedc2inhumantumors AT yutinglu pancanceranalysisoftheprognosticimplicationandoncogenicroleoftubulinepsilonanddeltacomplex2tedc2inhumantumors AT kepan pancanceranalysisoftheprognosticimplicationandoncogenicroleoftubulinepsilonanddeltacomplex2tedc2inhumantumors AT chuantong pancanceranalysisoftheprognosticimplicationandoncogenicroleoftubulinepsilonanddeltacomplex2tedc2inhumantumors AT yaowang pancanceranalysisoftheprognosticimplicationandoncogenicroleoftubulinepsilonanddeltacomplex2tedc2inhumantumors |